Novel intragenic deletions and point mutations of the ornithine transcarbamylase gene in congenital hyperammonemia
✍ Scribed by Patrick Calvas; Bertrand Ségues; Jean-Michel Rozet; Daniel Rabier; Jean-Paul Bonnefond; Arnold Munnich
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 320 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1059-7794
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The "private" nature of most mutations causing ornithine transcarbamylase (OTC) deficiency makes mutation identification in the patients difficult. Further, the PCR-amplification technology generally used for the genetic diagnosis of the deficiency misses large deletions in carrier females. Intragen
A new simple, non-invasive method using ornithine transcarbamylase (OTC) mRNA isolated from peripheral blood (PBL) or lymphoblastoid cell lines has been performed. This approach based on reverse transcription and nested PCR to obtain a double strand PBL OTC cDNA allowed the identification of genetic